{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:28:03Z","timestamp":1789781283469,"version":"4.0.1"},"reference-count":28,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2017\/16082-7"],"award-info":[{"award-number":["2017\/16082-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"abstract":"<jats:p>ABSTRACT  Background:  In this study, we aimed to describe the mutations associated with first-line drug resistance in Mycobacterium tuberculosis complex (MTBC) isolates from S\u00e3o Paulo, Brazil, between 2019 and 2021.  Methods:  Mutations in the coding regions of rpoB and katG genes and in the promoter region of the inhA gene in MTBC clinical isolates were detected using the GenoType MTBDRplus assay (LPA). All mutations inferred by LPA were sequenced.  Results:  Of the 13,489 MTBC isolates with valid LPA results, 657 (4.9%) harbored mutations. The overall prevalence rates of rifampicin-resistant (RIF-R) tuberculosis (TB), isoniazid-resistant (INH-R) TB, and multidrug-resistant (MDR) TB were 1.5, 2.0, and 1.2%, respectively. A significant proportion of RIF-R isolates presented inferred rpoB mutations (89.1%), most of which were the borderline H445N mutation. The inhA promoter C-15T mutation was predominant among the INH-R isolates (52.8%). Most MDR isolates presented rpoB S450L + katG S315T1 mutations. Gene sequencing identified mutations not included in the catalogue of mutations published by the World Health Organization. Phenotypic drug susceptibility testing on isolates with inferred rpoB mutations revealed that the 0.5 \u00b5g\/mL critical concentration of RIF failed to detect most borderline mutations when using the BACTEC MGIT 960 system.  Conclusions:  These findings emphasize the need for continuous surveillance and the integration of molecular and phenotypic methods to ensure an accurate detection and management of drug-resistant TB in high-burden settings.<\/jats:p>","DOI":"10.1590\/0037-8682-0184-2025","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T15:04:19Z","timestamp":1758553459000},"source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive analysis of mutations associated with rifampicin- and isoniazid-resistant tuberculosis in a high-burden setting"],"prefix":"10.1590","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5188-8367","authenticated-orcid":false,"given":"Ros\u00e2ngela Siqueira de","family":"Oliveira","sequence":"first","affiliation":[{"name":"Instituto Adolfo Lutz,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6036-9139","authenticated-orcid":false,"given":"Angela Pires","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Instituto Adolfo Lutz,  Brasil; Funda\u00e7\u00e3o Oswaldo Cruz,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8632-3736","authenticated-orcid":false,"given":"Fabiane Maria de Almeida","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Instituto Adolfo Lutz,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0838-480X","authenticated-orcid":false,"given":"Sonia Maria da","family":"Costa","sequence":"additional","affiliation":[{"name":"Instituto Adolfo Lutz,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3931-2199","authenticated-orcid":false,"given":"Vera Lucia Maria da","family":"Silva","sequence":"additional","affiliation":[{"name":"Instituto Adolfo Lutz,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-7056","authenticated-orcid":false,"given":"Lucilaine","family":"Ferrazoli","sequence":"additional","affiliation":[{"name":"Instituto Adolfo Lutz,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9574-8449","authenticated-orcid":false,"given":"Erica","family":"Chimara","sequence":"additional","affiliation":[{"name":"Instituto Adolfo Lutz,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5758-6688","authenticated-orcid":false,"given":"Juliana Maira Watanabe","family":"Pinhata","sequence":"additional","affiliation":[{"name":"Instituto Adolfo Lutz,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","series-title":"Global tuberculosis report","year":"2024"},{"key":"ref2","series-title":"Boletim Epidemiol\u00f3gico - Tuberculose","year":"2024"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","DOI":"10.1590\/1806-3713\/e20180128","article-title":"Speeding up the diagnosis of multidrug-resistant tuberculosis in a high-burden region with the use of a commercial line probe assay","volume":"45","author":"Brandao AP","year":"2019","journal-title":"J Bras Pneumol"},{"issue":"25","key":"ref4","doi-asserted-by":"crossref","first-page":"102004","DOI":"10.1016\/j.tube.2020.102004","article-title":"Transmission of Mycobacterium tuberculosis presenting unusually high discordance between genotypic and phenotypic resistance to rifampicin in an endemic tuberculosis setting","author":"Brandao AP","year":"2020","journal-title":"Tuberculosis"},{"issue":"115","key":"ref5","article-title":"Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from S\u00e3o Paulo, Brazil","author":"Matsui T","year":"2020","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref6","article-title":"The performance of Xpert MTB\/RIF and MTBDRplus within a Programmatic setting at TB Laboratory in Rio de Janeiro, Brazil","volume":"57","author":"Malaquias TDSS","year":"2024","journal-title":"Rev Soc Bras Med Trop"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1007\/s10096-021-04316-0","article-title":"Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting","volume":"40","author":"Pinhata JMW","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"115856","DOI":"10.1016\/j.diagmicrobio.2022.115856","article-title":"GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory","volume":"105","author":"Pinhata JMW","year":"2023","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10096-023-04693-8","article-title":"A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country","volume":"43","author":"Pinhata JMW","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1099\/jmm.0.000734","article-title":"Growth characteristics of liquid cultures increase the reliability of presumptive identification of Mycobacterium tuberculosis complex","volume":"67","author":"Pinhata JMW","year":"2018","journal-title":"J Med Microbiol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1590\/S1806-37132009001200008","article-title":"Cord factor detection and macroscopic evaluation of mycobacterial colonies: an efficient combined screening test for the presumptive identification of Mycobacterium tuberculosis complex on solid media","volume":"35","author":"Sime\u00e3o FC dos S","year":"2009","journal-title":"J Bras Pneumol"},{"key":"ref12","series-title":"Manual de recomenda\u00e7\u00f5es para o Controle da Tuberculose no Brasil","year":"2019"},{"issue":"02","key":"ref13","first-page":"1","article-title":"GenoType MTBDRplus VER 2.0 - Molecular Genetic Assay for Identification of the M. tuberculosis Complex and its Resistance to Rifampicin and Isoniazid from Clinical Specimens and Cultivated Samples","year":"2015","journal-title":"Hain lifescience"},{"key":"ref14","series-title":"Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis","year":"2018"},{"key":"ref15","series-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","year":"2023","edition":"2nd edition"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.diagmicrobio.2016.10.023","article-title":"Modified protocol for drug susceptibility testing of MGIT cultures of Mycobacterium tuberculosis by the MGIT 960","volume":"87","author":"Adami AG","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref17","series-title":"Technical Report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine)","year":"2021"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"2100783","DOI":"10.1183\/13993003.00783-2021","article-title":"Mycobacterium tuberculosis borderline rpoB mutations: Emerging from the unknown","volume":"58","author":"Van Deun A","year":"2021","journal-title":"Eur Respir J"},{"issue":"66","key":"ref19","article-title":"Impact of COVID-19 on tuberculosis notifications","volume":"7","author":"Pontes TAA","year":"2024","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"106401","DOI":"10.1016\/j.ijantimicag.2021.106401","article-title":"Genomic-based surveillance reveals high ongoing transmission of multi-drug-resistant Mycobacterium tuberculosis in Southern Brazil","volume":"58","author":"Salvato RS","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"ref21","first-page":"001109","article-title":"Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh","volume":"9","author":"Lempens P","year":"2023","journal-title":"Microb Genom"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"ofz065","DOI":"10.1093\/ofid\/ofz065","article-title":"rpoB Mutations Causing Discordant Rifampicin Susceptibility in Mycobacterium tuberculosis: Retrospective Analysis of Prevalence, Phenotypic, Genotypic, and Treatment Outcomes","volume":"6","author":"Mvelase NR","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01586-22","article-title":"Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia","volume":"10","author":"Claassens M","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.00112-06","article-title":"Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis","volume":"50","author":"Hazb\u00f3n MH","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"151506","DOI":"10.1016\/j.ijmm.2021.151506","article-title":"First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness","volume":"311","author":"De Maio F","year":"2021","journal-title":"Int J Med Microbiol"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1128\/AAC.39.10.2276","article-title":"Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare","volume":"39","author":"Pretorius GS","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1590\/S1806-37132009000800009","article-title":"Isoniazid-resistant Mycobacterium tuberculosis strains arising from mutations in two different regions of the katG gene","volume":"35","author":"Siqueira HR de","year":"2009","journal-title":"J Bras Pneumol"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01701-23","article-title":"Reduced critical concentration might not have improved MGIT- based DST\u2019s sensitivity to rifampicin","volume":"68","author":"Rupasinghe P","year":"2024","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0037-86822025000100413&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T15:04:23Z","timestamp":1758553463000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822025000100413&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"alternative-id":["S0037-86822025000100413"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0184-2025","relation":{},"ISSN":["1678-9849","0037-8682"],"issn-type":[{"value":"1678-9849","type":"electronic"},{"value":"0037-8682","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e0184-2025"}}